What is ADMA Biologics's total equity?

ADMA Biologics (ADMA) reported total equity of $390.33M in Q1 2026.

How has ADMA Biologics's total equity changed year-over-year?

ADMA Biologics's total equity increased by 4.5% year-over-year, from $373.42M to $390.33M.

What is the long-term trend for ADMA Biologics's total equity?

Over 5 years (2020 to 2025), ADMA Biologics's total equity has grown at a 40.2% compound annual growth rate (CAGR), from $88.25M to $477.32M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

ADMA Biologics ADMA Total Equity

Total Equity at other companies

AbCellera Biologics Inc.ABCL

$938.08M-8.3%

AnaptysBio, Inc.ANAB

$12.75M-62.5%

ZymeworksZYME

$163.59M-49.7%

Bio-Rad LaboratoriesBIO

$6.85B+2.6%

Quest DiagnosticsDGX

$7.37B+6.3%

BiohavenBHVN

$129.5M-50.1%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's total equity?: ADMA Biologics (ADMA) reported total equity of $390.33M in Q1 2026.
How has ADMA Biologics's total equity changed year-over-year?: ADMA Biologics's total equity increased by 4.5% year-over-year, from $373.42M to $390.33M.
What is the long-term trend for ADMA Biologics's total equity?: Over 5 years (2020 to 2025), ADMA Biologics's total equity has grown at a 40.2% compound annual growth rate (CAGR), from $88.25M to $477.32M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.